Is sarcopenia associated with an increased risk of all-cause mortality and functional disability?
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background While a recent meta‐analysis of observational studies reported a statistically significant association between sarcopenia and both all‐cause mortality and functional decline, a recently developed inverse heterogeneity (IVhet) model has been shown to be more valid than the traditional random‐effects model used. Objective The objective of this short report was to use a previous meta‐analysis to compare the two approaches. Methods Aggregate data meta‐analysis of prospective observational studies conducted in any setting. Men and women 60 years of age and older in which all‐cause mortality (12 studies, 14,169 participants) or functional decline (6 studies, 8561 participants) was assessed. Using the IVhet model, pooling of previous studies regarding the association between sarcopenia and all‐cause mortality as well as functional decline. Absolute and relative differences between IVhet and random‐effects results were also calculated as well as influence analysis with each study deleted once. Non‐overlapping 95% confidence intervals (CI) for odds ratios (OR) were considered statistically significant. Results Sarcopenia was associated with an increased risk for all‐cause mortality (OR = 3.64, 95% CI = 2.94 to 4.51) and functional decline (OR = 2.58, 95% CI = 1.33 to 4.99). Compared to the random‐effects model, the OR was slightly higher (0.04 or 1.1%) but with wider CI (0.16 or 11.3%) for all‐cause mortality and 0.45 (14.9%) lower with a CI that was 0.34 (10.2%) wider for functional decline. With each study deleted from the model once, results remained statistically significant for both all‐cause mortality and functional decline. Conclusion These results provide additional and more accurate evidence in support of an association between sarcopenia and an increased risk for both all‐cause mortality and functional decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The healthcare costs of sarcopenia in the United States
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., & Roubenoff, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52014.x · Cited by 1,546
An overview of sarcopenia: facts and numbers on prevalence and clinical impact
von Haehling, S., Morley, J. E., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0014-2 · Cited by 888
Cited by
Kitamura, A., Seino, S., Abe, T., Nofuji, Y., Yokoyama, Y., Amano, H., Nishi, M., Taniguchi, Y., Narita, M., Fujiwara, Y., et al. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12651 · Cited by 457
Understanding the gut microbiota and sarcopenia: a systematic review
Liu, C., Cheung, W., Li, J., Chow, S. K., Yu, J., Wong, S. H., Ip, M., Sung, J. J. Y., & Wong, R. M. Y. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12784 · Cited by 363
Hsu, K.-J., Liao, C.-D., Tsai, M.-W., & Chen, C.-N. (2019) · Nutrients · doi:10.3390/nu11092163 · Cited by 258
Weight management and physical activity throughout the cancer care continuum
Demark‐Wahnefried, W., Schmitz, K. H., Alfano, C. M., Bail, J. R., Goodwin, P. J., Thomson, C. A., Bradley, D. W., Courneya, K. S., Befort, C. A., Denlinger, C. S., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21441 · Cited by 172
Morikawa, M., Lee, S., Makino, K., Harada, K., Katayama, O., Tomida, K., Yamaguchi, R., Nishijima, C., Fujii, K., Misu, Y., et al. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.03.008 · Cited by 41
Metadata
- Authors
- Kelley, G. A., & Kelley, K. S.
- Venue
- Experimental Gerontology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 96
- Pages
- 100-103
- ISSN
- 0531-5565 (ISSN-L)
- OpenAlex
- W2641628257
- Cited by
- 106
- References
- 2
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.